News Medical

PD-1 helps guide immune memory cells to the skin early during infection

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune ...
ascopubs.org

Association between PD-1 expression on tumor-infiltrating regulatory T cells and resistance to first-line nivolumab in advanced clear cell renal cell carcinoma: Insights from ...

Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
EurekAlert!

PD-1 + IL-2 power couple: Wake up 'sleepy' T cells to turbo-charge cancer cures

Researchers at Peking Union Medical College Hospital have mapped out why pairing two well-known cancer drugs can turn “sleepy” immune cells back into tumor killers. In a new Perspective published ...
The American Journal of Managed Care

PD-1, PD-L1 Agents Improve Outcomes for Cutaneous Squamous Cell Carcinoma: Todd Schlesinger, MD

Immunotherapies are transforming treatment and improving outcomes for patients with advanced cSCC, according to Todd Schlesinger, MD. In part 1 of the interview, he described how cSCC compares with ...
Pharmabiz

MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026

MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026: New York Monday, April 6 ...